Navigation Links
MU College of Veterinary Medicine to study efficacy of cancer drug in dogs
Date:10/5/2010

COLUMBIA, Mo. A cancer drug that benefits people may soon benefit man's best friend.

Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol in dogs with naturally occurring cancer. Attaxol was developed, and is produced, by CritiTech, a Lawrence, Kan. drug development company.

Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine.

"Cancer is one of the most common causes of death in dogs," Selting said. "This study is important because most chemotherapy drugs available to people can be used in dogs, except for the highly successful taxanes that can keep cancer from proliferating throughout the body. The Attaxol formulation is built specifically for dogs and could allow taxanes to be used by veterinarians."

MU veterinarians will conduct the clinical part of the study and assess cancer response in the dogs involved in the study. Data from an earlier safety study was used to establish a starting dose, and this second study will consist of an escalation phase to determine the optimal dose, followed by an extended treatment. CritiTech scientists will analyze blood samples to determine plasma levels of the drug during the course of treatment. Enrollment of dogs in the study is set to start in mid October, and it is anticipated that the study will take about two years to complete.

The Scott Endowed Program in Veterinary Oncology at MU is one of the largest veterinary oncology programs in the country and actively initiates and participates in clinical trials, as well as provides routine treatment of animals with cancer, including chemotherapy, cancer surgery and radiation therapy.

"We are excited about our continued collaboration with the University of Missouri College of Veterinary Medicine and the commercial opportunity to use CritiTech's fine-particle drug technology in the veterinary field," said Sam Campbell, CritiTech president and chairman.


'/>"/>

Contact: Steven Adams
AdamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Related biology news :

1. American College of Medical Genetics receives $13.5M NIH contract
2. Better beer: College team creating anticancer brew
3. College students find comfort in their pets during hard times
4. Texas College Police Unit Deploys BIO-key(R) Mobile Data System
5. High school students paper published in prestigious college math journal
6. NYU College of Dentistry awarded $1.9 million NIH grant for HIV research
7. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
8. Imperial College London and NTU collaborate to offer joint Ph.D. programs in engineering and science
9. Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
10. Genetic secrets of date palm unlocked by researchers at Weill Cornell Medical College in Qatar
11. American College of Medical Genetics affirms importance of newborn screening dried blood spots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology: